title: Capecitabine-induced leukocytoclastic vasculitis under neoadjuvant chemotherapy for locally advanced colorectal cancer.
abstract: We describe a case of capecitabine-induced leukocytoclastic vasculitis in a patient with locally advanced rectal cancer under curative neoadjuvant concurrent chemoradiation using capecitabine. After 5 days of the initiation of capecitabine the patient developed a pruritic maculopapular rash in her extremities consistent with vasculitis which was confirmed on skin biopsy without any signs of systemic involvement. Capecitabine was held and the rash was treated with topical steroids with complete resolution of both rash and pruritus. Due to a lack of other alternative chemotherapeutic options and the cutaneous-only involvement of vasculitis, the capecitabine was re-introduced. Two days later, the patient developed an identical maculopapular rash with a similar distribution. Prednisone was initiated while the capecitabine was continued with complete resolution of the rash. The patient successfully completed her curative neoadjuvant chemoradiation therapy treatment without the need to permanently discontinue the capecitabine.
authors.affiliation: 1 Department of Gastrointestinal Medical Oncology, 2 Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, TX 77030, USA.
authors.forename: Humaid O
authors.initials: HO
authors.lastname: Al-Shamsi
authors.affiliation: 1 Department of Gastrointestinal Medical Oncology, 2 Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, TX 77030, USA.
authors.forename: Bryan K
authors.initials: BK
authors.lastname: Kee
authors.affiliation: 1 Department of Gastrointestinal Medical Oncology, 2 Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, TX 77030, USA.
authors.forename: Michael T
authors.initials: MT
authors.lastname: Tetzlaff
authors.affiliation: 1 Department of Gastrointestinal Medical Oncology, 2 Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, TX 77030, USA.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Wolff
keywords: Leukocytoclastic vasculitis; capecitabine; chemotherapy-associated toxicity; colorectal cancer